ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 37 filers reported holding ASCENDIS PHARMA A/S in Q1 2017. The put-call ratio across all filers is - and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,229,000 | +1517.1% | 13,190 | +2135.6% | 0.00% | – |
| Q1 2021 | $76,000 | -25.5% | 590 | 0.0% | 0.00% | – |
| Q4 2020 | $102,000 | +6.2% | 590 | 0.0% | 0.00% | – |
| Q3 2020 | $96,000 | +15.7% | 590 | 0.0% | 0.00% | – |
| Q2 2020 | $83,000 | +27.7% | 590 | 0.0% | 0.00% | – |
| Q1 2020 | $65,000 | -77.0% | 590 | -70.8% | 0.00% | – |
| Q4 2019 | $282,000 | +41.7% | 2,024 | -2.1% | 0.00% | – |
| Q3 2019 | $199,000 | -14.6% | 2,067 | +2.1% | 0.00% | – |
| Q2 2019 | $233,000 | -41.8% | 2,024 | -40.4% | 0.00% | – |
| Q1 2019 | $400,000 | +93.2% | 3,396 | +2.7% | 0.00% | – |
| Q4 2018 | $207,000 | -11.5% | 3,308 | 0.0% | 0.00% | – |
| Q3 2018 | $234,000 | +6.4% | 3,308 | 0.0% | 0.00% | – |
| Q2 2018 | $220,000 | +1.9% | 3,308 | 0.0% | 0.00% | – |
| Q1 2018 | $216,000 | +31.7% | 3,308 | -19.3% | 0.00% | – |
| Q4 2017 | $164,000 | +10.1% | 4,098 | 0.0% | 0.00% | – |
| Q3 2017 | $149,000 | +18.3% | 4,098 | -9.6% | 0.00% | – |
| Q2 2017 | $126,000 | +125.0% | 4,535 | +127.4% | 0.00% | – |
| Q1 2017 | $56,000 | – | 1,994 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 1,797,745 | $265,886,000 | 19.06% |
| RA Capital Management | 4,914,955 | $726,922,000 | 14.16% |
| Sofinnova Investments, Inc. | 1,109,874 | $164,150,000 | 10.35% |
| Eventide Asset Management | 1,709,848 | $252,887,000 | 5.50% |
| Asymmetry Capital Management, L.P. | 47,599 | $7,040,000 | 5.39% |
| BERYLSON CAPITAL PARTNERS, LLC | 58,200 | $8,608,000 | 5.30% |
| Avoro Capital Advisors LLC | 1,750,000 | $258,825,000 | 5.12% |
| Eversept Partners, LP | 220,344 | $32,588,878 | 4.47% |
| Spyglass Capital Management LLC | 452,104 | $66,866,000 | 4.14% |
| Orbimed Advisors | 1,562,986 | $231,166,000 | 3.25% |